Google Ventures, formed back in March, has made its first investment into a biotech company, according to Fierce Biotech. The company invested about $13 million into antibody start-up Adimabm, which uses computational approaches to develop its antibody library. Google Venture plans to invest $100 million in biotech in the coming year. "Google Ventures has a pretty broad mandate," managing partner William Maris says to Dow Jones. "We're looking for [companies] that have potential to make a big impact."